INS and type 1 diabetes mellitus: Models that try to resemble human pDN (Gao and Zheng 2014) include high-dose streptozotocin that is toxic to pancreatic insulin-secreting β-cells and genetically modified strains are used to mimic the metabolic phenotype of T1DM.